Undiagnosed HIV infection among New York City jail entrants, 2006: results of a blinded serosurvey.

J Acquir Immune Defic Syndr

New York City Department of Health and Mental Hygiene, 346 Broadway, Room 707, New York, NY 10013, USA.

Published: May 2010

Objective: Since 2004, when all New York City jail entrants began being offered rapid testing at medical intake, HIV testing has increased 4-fold. To guide further service improvement, we determined HIV prevalence among jail entrants, including proportion undiagnosed.

Methods: Remnant serum from routine syphilis screening was salvaged for blinded HIV testing in 2006. Using HIV surveillance data and electronic clinical data, we ascertained previously diagnosed HIV infections before permanently removing identifiers. We defined "undiagnosed" as HIV-infected entrants who were unreported to surveillance and denied HIV infection.

Results: Among the 6411 jail entrants tested (68.9% of admissions), HIV prevalence was 5.2% overall (males 4.7%; females: 9.8%). Adjusting for those not in the serosurvey, estimated seroprevalence is 8.7% overall (6.5% males, 14% females). Overall, 28.1% of HIV infections identified in the serosurvey were undiagnosed at jail entry; only 11.5% of these were diagnosed during routine jail testing. Few (11.1%) of the undiagnosed inmates reported injection drug use or being men who have sex with men.

Conclusions: About 5%-9% of New York City jail entrants are HIV infected. Of the infected, 28% are undiagnosed; most of whom denied recognized HIV risk factors. To increase inmate's acceptance of routine testing, we are working to eliminate the required separate written consent for HIV testing to allow implementation of the Centers for Disease Control and Prevention-recommended opt out testing model.

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAI.0b013e3181c98fa8DOI Listing

Publication Analysis

Top Keywords

jail entrants
20
york city
12
city jail
12
hiv testing
12
hiv
11
hiv prevalence
8
hiv infections
8
jail
7
testing
7
entrants
6

Similar Publications

Article Synopsis
  • A new Medicaid Reentry Section 1115 Demonstration Opportunity could significantly expand prerelease and transition services for incarcerated individuals, particularly benefiting smaller and rural states with high eligibility rates.
  • Incarcerated populations show high prevalence of mental illness and chronic diseases, which may impact overall health statistics within Medicaid.
  • The study calls for state Medicaid plans to enhance data exchange and service delivery systems to better accommodate the health needs of this transitioning population.
View Article and Find Full Text PDF

Background: Chlamydia and gonorrhea are 2 of the most common sexually transmitted infections (STIs) worldwide, presenting major public health challenges and resulting in billions of dollars in direct medical costs in the United States. Incarcerated women have a particularly elevated risk of these infections, which can result in serious sequelae if left untreated. On December 13, 2021, the Los Angeles County Jail system began offering opt-out urogenital chlamydia and gonorrhea screening to all newly incarcerated women.

View Article and Find Full Text PDF

HIV testing in jails: Comparing strategies to maximize engagement in HIV treatment and prevention.

PLoS One

June 2023

Divisions of General Internal Medicine & Infectious Diseases, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York, United States of America.

Despite 15,000 people enter US jails yearly with undiagnosed HIV infection, routine HIV testing is not standard. Maximizing the yield and speed of HIV testing in short-term detention facilities could promote rapid entry or re-entry of people living with HIV (PLWH) into care. The goal of this study was to evaluate the impact of third generation, rapid point-of-care (rPOC) vs.

View Article and Find Full Text PDF

Individuals who have experienced incarceration have an increased risk of both fatal and nonfatal overdose. Given the increases in illicit opioid use in Arkansas and across the South, many individuals with opioid use disorder (OUD) are likely to encounter the criminal justice system, particularly county jails. However, there are currently no published data on OUD among entrants into county jails in the South.

View Article and Find Full Text PDF

Screening and treating correctional populations for HIV and HCV infections is essential to successfully addressing both epidemics in the USA. The prevalence of HIV and HCV infection is high in prisons and jails due to increased rates of incarceration among disproportionately affected groups such as injection drug users. Through a search of the published and grey literature and surveying persons overseeing health programs in prisons, we collected data on efforts to determine prevalence first for HIV and then for HCV.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!